Recruitment is underway in Cambridge for volunteers to take part in clinical trials of a revolutionary new needle-free vaccine to protect against SARS-CoV-2 –

Individuals who are obese may be more susceptible to severe COVID-19 because of a poorer inflammatory immune response, say Cambridge scientists.

You’d be surprised how far back the roots of anti-vaccine arguments stretch.

The new bivalent boosters against COVID-19 have failed to halt omicron infections. However, new technologies are being developed that pave a way forward.

COVID-19 vaccinations that combine two or more distinct variants of the SARS-CoV-2 virus could offer protection against both current and future ‘variants of

A wealth of research on social media shows that COVID-19 misinformation is damaging to public health.

A drug used to reduce the risk of blood clots does not help patients recovering from moderate and severe COVID-19, despite this approach being offered to

Cambridge scientists have used synthetic biology to create artificial enzymes programmed to target the genetic code of SARS-CoV-2 and destroy the virus, an

A recent preprint suggesting SARS-CoV-2 came from a lab has reignited the fierce debate over the origins of the virus.

A cultural collaboration with deafblind people led to the development of a high-tech device to help navigate their world post-lockdown